43.68
2.79%
-1.36
Finanzdaten der Apogee Therapeutics Inc-Aktie (APGE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-09-30 |
Periodenlänge | 3 Monate | 3 Monate |
Revenues |
-
|
- |
Operating Expenses
|
57.09%
38.18
|
24.30 |
Operating Income/Loss |
57.09%
-38.18
|
-24.30 |
Income/Loss From Continuing Operations Before Tax |
54.00%
-32.09
|
-20.84 |
Income/Loss From Continuing Operations After Tax |
54.00%
-32.09
|
-20.84 |
Net Income/Loss
|
54.00%
-32.09
|
-20.84 |
Preferred Stock Dividends And Other Adjustments |
-
|
- |
Attributable To Noncontrolling Interest |
-
|
- |
Basic Average Shares |
21.73%
50.19
|
41.23 |
Diluted Average Shares |
21.73%
50.19
|
41.23 |
Basic Earnings Per Share |
25.49%
-0.64
|
-0.51 |
Diluted Earnings Per Share |
25.49%
-0.64
|
-0.51 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):